TD Asset Management’s Revolution Medicines RVMD Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $18.7M | Buy |
507,600
+181,724
| +56% | +$6.69M | 0.02% | 506 |
|
2025
Q1 | $11.5M | Buy |
325,876
+44,490
| +16% | +$1.57M | 0.01% | 603 |
|
2024
Q4 | $12.3M | Buy |
281,386
+37,852
| +16% | +$1.66M | 0.01% | 608 |
|
2024
Q3 | $10.8M | Sell |
243,534
-6,660
| -3% | -$294K | 0.01% | 629 |
|
2024
Q2 | $9.71M | Sell |
250,194
-4,400
| -2% | -$171K | 0.01% | 624 |
|
2024
Q1 | $8.21M | Sell |
254,594
-17,166
| -6% | -$553K | 0.01% | 660 |
|
2023
Q4 | $7.79M | Sell |
271,760
-64
| -0% | -$1.84K | 0.01% | 659 |
|
2023
Q3 | $7.52M | Buy |
271,824
+140,012
| +106% | +$3.88M | 0.01% | 638 |
|
2023
Q2 | $3.53M | Sell |
131,812
-2,700
| -2% | -$72.2K | ﹤0.01% | 814 |
|
2023
Q1 | $2.91M | Buy |
134,512
+40,339
| +43% | +$874K | ﹤0.01% | 877 |
|
2022
Q4 | $2.24M | Hold |
94,173
| – | – | ﹤0.01% | 949 |
|
2022
Q3 | $1.84M | Buy |
94,173
+13,876
| +17% | +$271K | ﹤0.01% | 1024 |
|
2022
Q2 | $1.57M | Sell |
80,297
-8,103
| -9% | -$158K | ﹤0.01% | 1076 |
|
2022
Q1 | $2.26M | Buy |
88,400
+15,400
| +21% | +$393K | ﹤0.01% | 1051 |
|
2021
Q4 | $1.84M | Hold |
73,000
| – | – | ﹤0.01% | 1152 |
|
2021
Q3 | $2.01M | Buy |
73,000
+44,600
| +157% | +$1.23M | ﹤0.01% | 1082 |
|
2021
Q2 | $813K | Buy |
+28,400
| New | +$813K | ﹤0.01% | 1298 |
|
2020
Q3 | – | Sell |
-9,370
| Closed | -$296K | – | 1394 |
|
2020
Q2 | $296K | Hold |
9,370
| – | – | ﹤0.01% | 1266 |
|
2020
Q1 | $205K | Buy |
+9,370
| New | +$205K | ﹤0.01% | 1314 |
|